Moderator, Start-up Workshop Panel
Moderator - Ewa Lis
CEO, Koliber Biosciences Inc.
Koliber Biosciences is an early-stage biotechnology company with a unique Artificial Intelligence platform for peptide drug discovery. The platform facilitates training of on-purpose machine learning models using a wide variety of pre-clinical datasets including NGS phage display and in vitro assay data accelerating both hit identification and lead optimization. The models enable scientists to design improved peptide variants, gain knowledge on key drivers and test selected peptides to gain stronger IP protection. The Koliber platform has been extensively validated on peptide datasets in several application areas including immunology, metabolic disease and antimicrobials. The company is based in San Diego, CA with a world-class team of advisors with expertise in peptide drug discovery (Amylin, Ferring), immunology (Pfizer), machine learning and software development (Kratos).
Ewa Lis Ph.D. is a Founder and CEO of Koliber Biosciences. Ewa specializes in building Artificial Intelligence systems to solve biological data problems. Her unique expertise spans both computer science including deep learning, data augmentation and graph networks as well as several areas of biological and chemical sciences. Prior to founding Koliber in 2014, Ewa held leadership positions at Life Technologies, Genomatica and Reveal Biosciences, where she developed innovative technologies from algorithms for pathology tissue classification to genome engineering research tools and microbially derived renewable chemicals. Ewa holds a BA in Chemistry from Cornell University and a Ph.D. in Biological Sciences from The Scripps Research Institute.